Lori M. van Roozendaal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lori M. van Roozendaal has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
- Erik Robert de Loos
Department of surgery, Division of general thoracic surgery, Zuyderland Medical Center, Heerlen, the Netherlands
7 shared publications - Yvonne L. J. Vissers
Division of General Thoracic Surgery, Department of Surgery, Zuyderland Medical Center, Heerlen, The Netherlands
7 shared publications - Aimee J. P. M. Franssen
Department of surgery, Division of general thoracic surgery, Zuyderland Medical Center, Heerlen, the Netherlands
6 shared publications - Marjolein L. Smidt
Department of Surgery, Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands
5 shared publications - Iris E. W. G. Laven
Division of General Thoracic Surgery, Department of Surgery, Zuyderland Medical Center, Heerlen, The Netherlands
4 shared publications - Karel W. E. Hulsewe
Department of surgery, Division of general thoracic surgery, Zuyderland Medical Center, Heerlen, the Netherlands
4 shared publications
Latest Publications
- 16 March 2026
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 68 (4)
A Network Meta-Analysis of Drainage Systems and Suction Strategies After Lung Cancer Surgery
Objectives: Optimizing chest drainage management after lung cancer surgery plays a pivotal role in minimizing drainage time and shortening length of hospital stay (LOHS). Currently, a universally acceptable standard is lacking, and a wide range of drain management strategies are practiced. Therefore, the aim of this systematic review and network meta-analysis (NMA) was to determine an optimal chest drain management strategy following anatomical lung resection on drainage duration, LOHS, and complications, while maintaining patient safety. Methods: A systematic search was conducted in PubMed, Embase, ClinicalTrials.gov, and Cochrane Library; last search December 2025. Studies were included if they investigated drain management following anatomical lung resection and reported at least one of the following outcomes: drain duration, LOHS, or complications. Network meta-analysis were performed to integrate both direct and indirect comparisons to identify the optimal drain management strategy. Results: Seventeen studies (2004-2023), encompassing 2929 patients, were included in the NMA. Eight distinct drainage strategies were identified based on digital or analogue drainage system, and types of suction: continuous, short-term, alternating suction, or water-seal. In general, digital drainage with alternating suction tended to be associated with shorter drainage duration and LOHS when compared with other drainage strategies. Major complications (Clavien-Dindo ≥3) were reported in 13 studies, varying from 0% to 21%. Conclusions: Digital drainage systems may reduce drainage duration and LOHS compared with analogue systems. Continuous suction appears less effective than water seal or alternating suction. Due to heterogeneity, firm conclusions are limited and should be interpreted with utmost caution, highlighting the need for standardized high-quality studies.
- 16 March 2026
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 68 (4)
A Network Meta-Analysis of Drainage Systems and Suction Strategies After Lung Cancer Surgery
Objectives: Optimizing chest drainage management after lung cancer surgery plays a pivotal role in minimizing drainage time and shortening length of hospital stay (LOHS). Currently, a universally acceptable standard is lacking, and a wide range of drain management strategies are practiced. Therefore, the aim of this systematic review and network meta-analysis (NMA) was to determine an optimal chest drain management strategy following anatomical lung resection on drainage duration, LOHS, and complications, while maintaining patient safety. Methods: A systematic search was conducted in PubMed, Embase, ClinicalTrials.gov, and Cochrane Library; last search December 2025. Studies were included if they investigated drain management following anatomical lung resection and reported at least one of the following outcomes: drain duration, LOHS, or complications. Network meta-analysis were performed to integrate both direct and indirect comparisons to identify the optimal drain management strategy. Results: Seventeen studies (2004-2023), encompassing 2929 patients, were included in the NMA. Eight distinct drainage strategies were identified based on digital or analogue drainage system, and types of suction: continuous, short-term, alternating suction, or water-seal. In general, digital drainage with alternating suction tended to be associated with shorter drainage duration and LOHS when compared with other drainage strategies. Major complications (Clavien-Dindo ≥3) were reported in 13 studies, varying from 0% to 21%. Conclusions: Digital drainage systems may reduce drainage duration and LOHS compared with analogue systems. Continuous suction appears less effective than water seal or alternating suction. Due to heterogeneity, firm conclusions are limited and should be interpreted with utmost caution, highlighting the need for standardized high-quality studies.
- Open Access
- 1 August 2025
- Published by AME Publishing Company in Translational Lung Cancer Research
- Vol. 14 (8) , 3126-3141
Advancements in 3D lung models for minimally invasive lung cancer surgery: from static to real-time dynamic modeling
Three-dimensional (3D) lung models have become a valuable tool in surgical planning and intraoperative navigation by providing detailed visualizations of pulmonary structures (e.g., bronchial tree, pulmonary vasculature, lung parenchyma, and tumor). These models are useful in minimally invasive lung cancer surgery, particularly for more complex segmentectomy procedures, where precise anatomical understanding is important. Enhancing the spatial insight of patient-specific anatomical variations facilitates precise lung nodule localization, supports decision-making regarding the extent of lung resection, and contributes to a smoother surgical procedure and intraoperative efficiency. In contrast to earlier reports that have addressed specific technologies, this review article provides a thorough overview of the advancements in 3D lung modeling, covering various technologies and their clinical applications—from conventional on-screen visualizations to advanced imaging modalities such as virtual reality (VR), augmented reality (AR), mixed reality (MR), and insights into the future of real-time dynamic lung simulations in minimally invasive lung cancer surgery. In addition, this review touches upon the various segmentation methods, such as surface rendering, volume rendering, and artificial intelligence (AI) algorithms, and different types of software programs (i.e., commercial and open-source software programs) for developing these 3D lung models. It emphasizes its practical integration in thoracic surgical practice, highlighting the clinical value in preoperative planning and intraoperative guidance, with evidence showing improved surgical outcomes and reduced surgery duration for both segmentectomy and lobectomy, along with the added value for education, training purposes, and enhanced patient counseling. Evidence should be strengthened through more robust comparative studies evaluating different (advanced) imaging modalities and software programs to demonstrate their cost-effectiveness. Moreover, technical challenges in the integration of these 3D modeling tools must be overcome to limit the need for specialized software and personnel.
- 1 August 2025
- Published by AME Publishing Company in Translational Lung Cancer Research
- Vol. 14 (8) , 3126-3141
Open AccessAdvancements in 3D lung models for minimally invasive lung cancer surgery: from static to real-time dynamic modeling
Three-dimensional (3D) lung models have become a valuable tool in surgical planning and intraoperative navigation by providing detailed visualizations of pulmonary structures (e.g., bronchial tree, pulmonary vasculature, lung parenchyma, and tumor). These models are useful in minimally invasive lung cancer surgery, particularly for more complex segmentectomy procedures, where precise anatomical understanding is important. Enhancing the spatial insight of patient-specific anatomical variations facilitates precise lung nodule localization, supports decision-making regarding the extent of lung resection, and contributes to a smoother surgical procedure and intraoperative efficiency. In contrast to earlier reports that have addressed specific technologies, this review article provides a thorough overview of the advancements in 3D lung modeling, covering various technologies and their clinical applications—from conventional on-screen visualizations to advanced imaging modalities such as virtual reality (VR), augmented reality (AR), mixed reality (MR), and insights into the future of real-time dynamic lung simulations in minimally invasive lung cancer surgery. In addition, this review touches upon the various segmentation methods, such as surface rendering, volume rendering, and artificial intelligence (AI) algorithms, and different types of software programs (i.e., commercial and open-source software programs) for developing these 3D lung models. It emphasizes its practical integration in thoracic surgical practice, highlighting the clinical value in preoperative planning and intraoperative guidance, with evidence showing improved surgical outcomes and reduced surgery duration for both segmentectomy and lobectomy, along with the added value for education, training purposes, and enhanced patient counseling. Evidence should be strengthened through more robust comparative studies evaluating different (advanced) imaging modalities and software programs to demonstrate their cost-effectiveness. Moreover, technical challenges in the integration of these 3D modeling tools must be overcome to limit the need for specialized software and personnel.
- Open Access
- 1 May 2025
- Published by AME Publishing Company in Translational Lung Cancer Research
- Vol. 14 (5) , 1496-1499
Pneumonectomy—a necessary evil?
Pneumonectomy—a necessary evil?
- 1 May 2025
- Published by AME Publishing Company in Translational Lung Cancer Research
- Vol. 14 (5) , 1496-1499
Open AccessPneumonectomy—a necessary evil?
Pneumonectomy—a necessary evil?
- 1 January 2025
- Published by SAGE Publications in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
- Vol. 20 (1) , 87-95
Three-Dimensional Lung Reconstructions for Preoperative Planning of Uniportal Video-Assisted Thoracoscopic Segmentectomies Using Visible Patient Software
In this article, we present the use of 3-dimensional (3D) lung reconstructions performed by Visible Patient software and share our experience with the first 5 patients who were scheduled for a segmentectomy. These reconstructions provided useful insights into more accurate lung nodule locations, resulting in a preoperative change in the surgical plan in 3 of the 5 patients. In addition, surgeons were better prepared for surgery with the preoperative knowledge of anatomical variations identified in 4 patients. These findings highlight the critical role of preoperative 3D lung reconstructions in determining the appropriate surgical indication and refining the surgical plan when thoracoscopic segmentectomy is initially indicated.
- 1 January 2025
- Published by SAGE Publications in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
- Vol. 20 (1) , 87-95
Three-Dimensional Lung Reconstructions for Preoperative Planning of Uniportal Video-Assisted Thoracoscopic Segmentectomies Using Visible Patient Software
In this article, we present the use of 3-dimensional (3D) lung reconstructions performed by Visible Patient software and share our experience with the first 5 patients who were scheduled for a segmentectomy. These reconstructions provided useful insights into more accurate lung nodule locations, resulting in a preoperative change in the surgical plan in 3 of the 5 patients. In addition, surgeons were better prepared for surgery with the preoperative knowledge of anatomical variations identified in 4 patients. These findings highlight the critical role of preoperative 3D lung reconstructions in determining the appropriate surgical indication and refining the surgical plan when thoracoscopic segmentectomy is initially indicated.
- Open Access
- 1 July 2024
- Published by AME Publishing Company in Translational Lung Cancer Research
- Vol. 13 (7) , 1595-1608
Evaluating three-dimensional lung reconstructions for thoracoscopic lung resections using open-source software: a pilot study
Background: Preoperative three-dimensional (3D) lung reconstructions can reduce intraoperative blood loss, conversion rate, and operation duration. These 3D reconstructions are predominantly provided by commercial expensive products, hence we aimed to assess the usability and performance of preoperative 3D lung reconstructions created with open-source software. Methods: Patients were invited to participate in this prospective pilot study if they were planned for uniportal video-assisted thoracoscopic surgery (VATS) lobectomy or segmentectomy between January and February 2023. Participants were excluded if a two-dimensional (2D) late-arterial-phase computed tomography (CT) scan contained motion artifacts, another surgical procedure was performed, or the surgery was canceled. After informed consent was obtained, 3D lung reconstructions were constructed using open-source 3D Slicer software. The system usability score (SUS) questionnaire assessed the usability of these reconstructions, whilst performance was evaluated based on anatomical validity compared to prior 2D CT assessment as well as operative findings. Descriptive statistics were reported. Results: Thirteen patients were included, of whom one underwent a segmentectomy. Eighty-three percent of the 3D lung reconstructions scored above average (SUS >68). Compared to 2D CT scans, 38% of lung nodule segmental locations were detected more accurately through 3D lung reconstructions. Furthermore, 3D lung reconstructions revealed anatomical variations in 62%, which were not recognized on 2D CT scans, and provided surgeons with insights that would change the procedure and/or transection planes in 62%. One 3D lung reconstruction failed to demonstrate an intraoperative recognized segmental pulmonary artery (A6) branch. Conclusions: Three-dimensional lung reconstructions created with open-source software were usable and effective for uniportal VATS anatomical resections. Trial Registration: ClinicalTrials.gov/NCT06132607.
- 1 July 2024
- Published by AME Publishing Company in Translational Lung Cancer Research
- Vol. 13 (7) , 1595-1608
Open AccessEvaluating three-dimensional lung reconstructions for thoracoscopic lung resections using open-source software: a pilot study
Background: Preoperative three-dimensional (3D) lung reconstructions can reduce intraoperative blood loss, conversion rate, and operation duration. These 3D reconstructions are predominantly provided by commercial expensive products, hence we aimed to assess the usability and performance of preoperative 3D lung reconstructions created with open-source software. Methods: Patients were invited to participate in this prospective pilot study if they were planned for uniportal video-assisted thoracoscopic surgery (VATS) lobectomy or segmentectomy between January and February 2023. Participants were excluded if a two-dimensional (2D) late-arterial-phase computed tomography (CT) scan contained motion artifacts, another surgical procedure was performed, or the surgery was canceled. After informed consent was obtained, 3D lung reconstructions were constructed using open-source 3D Slicer software. The system usability score (SUS) questionnaire assessed the usability of these reconstructions, whilst performance was evaluated based on anatomical validity compared to prior 2D CT assessment as well as operative findings. Descriptive statistics were reported. Results: Thirteen patients were included, of whom one underwent a segmentectomy. Eighty-three percent of the 3D lung reconstructions scored above average (SUS >68). Compared to 2D CT scans, 38% of lung nodule segmental locations were detected more accurately through 3D lung reconstructions. Furthermore, 3D lung reconstructions revealed anatomical variations in 62%, which were not recognized on 2D CT scans, and provided surgeons with insights that would change the procedure and/or transection planes in 62%. One 3D lung reconstruction failed to demonstrate an intraoperative recognized segmental pulmonary artery (A6) branch. Conclusions: Three-dimensional lung reconstructions created with open-source software were usable and effective for uniportal VATS anatomical resections. Trial Registration: ClinicalTrials.gov/NCT06132607.
- Open Access
- 1 May 2024
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 16 (5) , 3484-3492
Management of soft tissue sarcomas of the chest wall: a comprehensive overview
Sarcomas of the chest wall are rare and their current treatment regimen is diverse and complex due to the heterogeneity of these tumors as well as the variations in tumor location and extent. They only account for 0.04% of newly diagnosed cancers of whom about 45% comprise soft tissue sarcomas. Larger cohort studies are scarce and often focus on one specific treatment item. We therefore aim to provide helicopter view for clinicians treating patients with sarcomas of the chest wall, focusing mainly on soft tissue sarcomas. This overview includes the value of neoadjuvant systemic or radiotherapy, surgical resection, approaches for thoracic wall reconstruction, and the need for follow-up. Provided the heterogeneity and relative rarity, we recommend that treatment decisions in soft tissue sarcoma of the chest wall are discussed in a multidisciplinary tumor board at a reference sarcoma center or within sarcoma networks to ensure personalized, rational decision making. A surgical oncologist specialized in sarcoma surgery is crucial, and for extensive resections involving the thoracic cavity we recommend involvement of a thoracic surgeon. In addition, a specialized medical- and radiation oncologist as well as a plastic surgeon is required to ensure the best multimodality treatment plan to optimize patient outcome.
- 1 May 2024
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 16 (5) , 3484-3492
Open AccessManagement of soft tissue sarcomas of the chest wall: a comprehensive overview
Sarcomas of the chest wall are rare and their current treatment regimen is diverse and complex due to the heterogeneity of these tumors as well as the variations in tumor location and extent. They only account for 0.04% of newly diagnosed cancers of whom about 45% comprise soft tissue sarcomas. Larger cohort studies are scarce and often focus on one specific treatment item. We therefore aim to provide helicopter view for clinicians treating patients with sarcomas of the chest wall, focusing mainly on soft tissue sarcomas. This overview includes the value of neoadjuvant systemic or radiotherapy, surgical resection, approaches for thoracic wall reconstruction, and the need for follow-up. Provided the heterogeneity and relative rarity, we recommend that treatment decisions in soft tissue sarcoma of the chest wall are discussed in a multidisciplinary tumor board at a reference sarcoma center or within sarcoma networks to ensure personalized, rational decision making. A surgical oncologist specialized in sarcoma surgery is crucial, and for extensive resections involving the thoracic cavity we recommend involvement of a thoracic surgeon. In addition, a specialized medical- and radiation oncologist as well as a plastic surgeon is required to ensure the best multimodality treatment plan to optimize patient outcome.
- Open Access
- 5 October 2023
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 203 (1) , 103-110
Gene expression profiles in clinically T1-2N0 ER+HER2− breast cancer patients treated with breast-conserving therapy: their added value in case sentinel lymph node biopsy is not performed
Purpose: Omitting sentinel lymph node biopsy (SLNB) in breast cancer treatment results in patients with unknown positive nodal status and potential risk for systemic undertreatment. This study aimed to investigate whether gene expression profiles (GEPs) can lower this risk in cT1-2N0 ER+ HER2– breast cancer patients treated with BCT. Methods: Patients were included if diagnosed between 2011 and 2017 with cT1-2N0 ER+ HER2– breast cancer, treated with BCT and SLNB, and in whom GEP was applied. Adjuvant chemotherapy recommendations based on clinical risk status (Dutch breast cancer guideline of 2020 versus PREDICT v2.1) with and without knowledge on SLNB outcome were compared to GEP outcome. We examined missing adjuvant chemotherapy indications, and the number of GEPs needed to identify one patient at risk for systemic undertreatment. Results: Of 3585 patients, 2863 (79.9%) had pN0 and 722 (20.1%) pN + disease. Chemotherapy was recommended in 1354 (37.8% guideline-2020) and 1888 patients (52.7% PREDICT). Eliminating SLNB outcome (n = 722) resulted in omission of chemotherapy recommendation in 475 (35.1% guideline-2020) and 412 patients (21.8% PREDICT). GEP revealed genomic high risk in 126 (26.5% guideline-2020) and 82 patients (19.9% PREDICT) in case of omitted chemotherapy recommendation in the absence of SLNB. Extrapolated to the whole group, this concerns 3.5% and 2.3%, respectively, resulting in the need for 28–44 GEPs to identify one patient at risk for systemic undertreatment. Conclusion: If no SLNB is performed, clinical risk status according to the guideline of 2020 and PREDICT predicts a very low risk for systemic undertreatment. The number of GEPs needed to identify one patient at risk for undertreatment does not justify its standard use.
- 5 October 2023
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 203 (1) , 103-110
Open AccessGene expression profiles in clinically T1-2N0 ER+HER2− breast cancer patients treated with breast-conserving therapy: their added value in case sentinel lymph node biopsy is not performed
Purpose: Omitting sentinel lymph node biopsy (SLNB) in breast cancer treatment results in patients with unknown positive nodal status and potential risk for systemic undertreatment. This study aimed to investigate whether gene expression profiles (GEPs) can lower this risk in cT1-2N0 ER+ HER2– breast cancer patients treated with BCT. Methods: Patients were included if diagnosed between 2011 and 2017 with cT1-2N0 ER+ HER2– breast cancer, treated with BCT and SLNB, and in whom GEP was applied. Adjuvant chemotherapy recommendations based on clinical risk status (Dutch breast cancer guideline of 2020 versus PREDICT v2.1) with and without knowledge on SLNB outcome were compared to GEP outcome. We examined missing adjuvant chemotherapy indications, and the number of GEPs needed to identify one patient at risk for systemic undertreatment. Results: Of 3585 patients, 2863 (79.9%) had pN0 and 722 (20.1%) pN + disease. Chemotherapy was recommended in 1354 (37.8% guideline-2020) and 1888 patients (52.7% PREDICT). Eliminating SLNB outcome (n = 722) resulted in omission of chemotherapy recommendation in 475 (35.1% guideline-2020) and 412 patients (21.8% PREDICT). GEP revealed genomic high risk in 126 (26.5% guideline-2020) and 82 patients (19.9% PREDICT) in case of omitted chemotherapy recommendation in the absence of SLNB. Extrapolated to the whole group, this concerns 3.5% and 2.3%, respectively, resulting in the need for 28–44 GEPs to identify one patient at risk for systemic undertreatment. Conclusion: If no SLNB is performed, clinical risk status according to the guideline of 2020 and PREDICT predicts a very low risk for systemic undertreatment. The number of GEPs needed to identify one patient at risk for undertreatment does not justify its standard use.
- 3 June 2022
- Published by Springer Nature in General Thoracic and Cardiovascular Surgery
- Vol. 70 (11) , 985-992
VATS-assisted surgical stabilization of rib fractures in flail chest: 1-year follow-up of 105 cases
Objectives Early surgical stabilization of flail chest has been shown to improve chest wall stability and diminish respiratory complications. The addition of video‑assisted thoracoscopic surgery (VATS) can diagnose and manage intrathoracic injuries and evacuate hemothorax. This study analyzed the outcome of our 7-year experience with VATS-assisted surgical stabilization of rib fractures (SSRF) for flail chest. Methods From January 2013 to December 2019, all trauma patients undergoing VATS-assisted SSRF for flail chest were included. Patient characteristics and complications during 1-year follow-up were reported. Results VATS‑assisted SSRF for flail chest was performed in 105 patients. Median age was 65 years (range 21–92). Median injury severity score was 16 (range 9–49). Hemothorax was evacuated with VATS in 80 patients (median volume 200 ml, range 25–2500). In 3 patients entrapped lung was freed from the fracture site and in 2 patients a diaphragm rupture was repaired. Median postoperative ICU admission was 2 days (range 1–41). Thirty-two patients (30%) had a post‑operative complication during admission and six patients (6%) a complication within 1 year. In-hospital mortality rate was 1%. Six patients (6%) died after discharge, due to causes unrelated to the original injury. Conclusions Addition of VATS to SSRF for flail chest seems helpful to diagnose and manage intrathoracic injuries and adequately evacuate hemothorax. The majority of complications are low grade and occur during admission. Further prospective research needs to be conducted to identify potential risk factors for complications and better selection for addition of VATS to improve care in the future.
- 3 June 2022
- Published by Springer Nature in General Thoracic and Cardiovascular Surgery
- Vol. 70 (11) , 985-992
VATS-assisted surgical stabilization of rib fractures in flail chest: 1-year follow-up of 105 cases
Objectives Early surgical stabilization of flail chest has been shown to improve chest wall stability and diminish respiratory complications. The addition of video‑assisted thoracoscopic surgery (VATS) can diagnose and manage intrathoracic injuries and evacuate hemothorax. This study analyzed the outcome of our 7-year experience with VATS-assisted surgical stabilization of rib fractures (SSRF) for flail chest. Methods From January 2013 to December 2019, all trauma patients undergoing VATS-assisted SSRF for flail chest were included. Patient characteristics and complications during 1-year follow-up were reported. Results VATS‑assisted SSRF for flail chest was performed in 105 patients. Median age was 65 years (range 21–92). Median injury severity score was 16 (range 9–49). Hemothorax was evacuated with VATS in 80 patients (median volume 200 ml, range 25–2500). In 3 patients entrapped lung was freed from the fracture site and in 2 patients a diaphragm rupture was repaired. Median postoperative ICU admission was 2 days (range 1–41). Thirty-two patients (30%) had a post‑operative complication during admission and six patients (6%) a complication within 1 year. In-hospital mortality rate was 1%. Six patients (6%) died after discharge, due to causes unrelated to the original injury. Conclusions Addition of VATS to SSRF for flail chest seems helpful to diagnose and manage intrathoracic injuries and adequately evacuate hemothorax. The majority of complications are low grade and occur during admission. Further prospective research needs to be conducted to identify potential risk factors for complications and better selection for addition of VATS to improve care in the future.
- Open Access
- 1 June 2021
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 47 (6) , 1292-1298
Conditional regional recurrence risk: The effect of event-free years in different subtypes of breast cancer
- 1 June 2021
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 47 (6) , 1292-1298
Open AccessConditional regional recurrence risk: The effect of event-free years in different subtypes of breast cancer
- Open Access
- 1 May 2020
- Published by Elsevier in Advances in Radiation Oncology
- Vol. 5 (3) , 511-515
Bronchopleural Fistula After Concurrent Chemoradiotherapy
- 1 May 2020
- Published by Elsevier in Advances in Radiation Oncology
- Vol. 5 (3) , 511-515
Open AccessBronchopleural Fistula After Concurrent Chemoradiotherapy